Health-care companies rose amid hopes for more lucrative drug developments. Roche rallied after the Swiss drug maker said its fenebrutinib drug candidate met primary goals in two late-stage trials for ...

Ironwood Pharmaceuticals' shares rose Monday after the company raised its full-year revenue guidance, following strong third-quarter results helped by higher prescription demand. Shares rose 27% to $2 ...

The mean percentage of calories consumed by adults from ultra-processed foods dropped 3 percentage points from 2018 to 2023, ...

It is good that Brussels has recognised that this is an issue not just here in Ireland, but in other member states — such as ...

Dominic Cipriano couldn't stop shaking. A drug dealer on the streets of Kensington had sold him a bag of what he thought was ...

The latest data on the burden of chronic kidney disease (CKD) in South Asia, indicating that 16% of the population is ...

Introduction Low‐ and middle-income countries (LMICs) suffer the highest rates of death and disability due to emergency ...

It can be difficult to determine what disease is affecting the veggies in your garden, but if you look closely, you can tell ...

Ionis Pharmaceuticals, Inc. maintains a Buy rating as its transformation to a commercial company accelerates. Learn more ...

Detailed price information for Corcept Therapeutics (CORT-Q) from The Globe and Mail including charting and trades.